Heidelberg Financial Statements From 2010 to 2025
| HPHA Stock | EUR 2.32 0.07 2.93% |
Check Heidelberg Pharma financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heidelberg Pharma's main balance sheet or income statement drivers, such as , as well as many indicators such as . Heidelberg financial statements analysis is a perfect complement when working with Heidelberg Pharma Valuation or Volatility modules.
Heidelberg |
Heidelberg Pharma AG Company Price To Sales Analysis
Heidelberg Pharma's Price to Sales ratio is typically used for valuing equity relative to its own past performance as well as to performance of other companies or market indexes. In most cases, the lower the ratio, the better it is for investors. However, it is advisable for investors to exercise caution when looking at price-to-sales ratios across different industries.
Current Heidelberg Pharma Price To Sales | 12.52 X |
Most of Heidelberg Pharma's fundamental indicators, such as Price To Sales, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Heidelberg Pharma AG is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
The most critical factor to remember is that the price of equity takes a firm's debt into account, whereas the sales indicators do not consider financial leverage. Generally speaking, Price to Sales ratio shows how much market values every dollar of the company's sales.
| Competition |
Based on the latest financial disclosure, Heidelberg Pharma AG has a Price To Sales of 12.5236 times. This is much higher than that of the sector and significantly higher than that of the Price To Sales industry. The price to sales for all Germany stocks is notably lower than that of the firm.
Heidelberg Pharma Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Heidelberg Pharma's current stock value. Our valuation model uses many indicators to compare Heidelberg Pharma value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Heidelberg Pharma competition to find correlations between indicators driving Heidelberg Pharma's intrinsic value. More Info.Heidelberg Pharma AG is rated # 5 in current valuation category among its peers. It is one of the top stocks in price to book category among its peers . The ratio of Current Valuation to Price To Book for Heidelberg Pharma AG is about 7,853,241 . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Heidelberg Pharma's earnings, one of the primary drivers of an investment's value.About Heidelberg Pharma Financial Statements
Heidelberg Pharma stakeholders use historical fundamental indicators, such as Heidelberg Pharma's revenue or net income, to determine how well the company is positioned to perform in the future. Although Heidelberg Pharma investors may analyze each financial statement separately, they are all interrelated. For example, changes in Heidelberg Pharma's assets and liabilities are reflected in the revenues and expenses on Heidelberg Pharma's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Heidelberg Pharma AG. Please read more on our technical analysis and fundamental analysis pages.
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in Heidelberg Stock
Heidelberg Pharma financial ratios help investors to determine whether Heidelberg Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Heidelberg with respect to the benefits of owning Heidelberg Pharma security.